MP06-17 GEMCITABINE PLUS PACLITAXEL AS THIRD LINE CHEMOTHERAPY: A FEASIBLE OPTION FOR METASTATIC UROTHELIAL CARCINOMA PATIENTS
Author(s) -
Taku Naiki,
Keitaro Iida,
Ryosuke Ando,
Toshiki Etani,
Noriyasu Kawai,
Takashi Nagai,
Yosuke Sugiyama,
Masahiro Kondo,
T. Okamura,
Takahiro Yasui
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.2178
Subject(s) - gemcitabine , medicine , oncology , chemotherapy , docetaxel , urothelial carcinoma , metastatic urothelial carcinoma , paclitaxel , cancer , bladder cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom